Borrelia anserina: Avian Spirochetosis – Tick-Borne Pathogenesis, Diagnosis, and Control

Introduction and Etiology

Avian spirochetosis is an acute, septicemic disease of domestic and wild birds caused by the spirochete bacterium Borrelia anserina [1, 2]. The organism is a member of the family Spirochaetaceae, order Spirochaetales, and is morphologically distinct from other pathogenic borreliae such as Borrelia burgdorferi sensu lato, which causes Lyme disease in mammals [3]. B. anserina is an obligate parasite of birds and is transmitted primarily by argasid (soft) ticks of the genus Argas, most notably Argas persicus, the fowl tick [1, 4]. The disease is distributed globally in tropical and subtropical regions where its tick vectors are endemic, causing significant economic losses in commercial poultry operations through mortality, reduced egg production, and weight loss [2, 5].

Morphology and Biophysical Characteristics

Borrelia anserina is a helical, motile spirochete measuring 8 to 20 micrometers in length and 0.2 to 0.3 micrometers in width [1, 3]. The bacterium possesses 5 to 8 periplasmic flagella (endoflagella) inserted at each pole, which are enclosed within the outer membrane sheath and facilitate a characteristic corkscrew motility [3, 6]. The cell wall is composed of a cytoplasmic membrane, a thin peptidoglycan layer, and an outer membrane containing lipoproteins and glycolipids [6]. The genome of B. anserina is a linear chromosome approximately 1.5 megabases in size, with a low guanine-cytosine (GC) content of approximately 28 to 30 percent, a feature shared with other borreliae [7]. The organism is microaerophilic and fastidious, requiring enriched media such as Barbour-Stoenner-Kelly (BSK) medium for in vitro cultivation, though primary isolation from clinical samples is often difficult due to its stringent growth requirements [1, 8].

Epidemiology and Tick-Borne Transmission

The primary vector for B. anserina is the fowl tick Argas persicus, a soft tick of the family Argasidae [4, 9]. A. persicus is a nocturnal, multi-host ectoparasite that infests poultry houses, roosts, and nesting sites [4]. The tick life cycle includes egg, larva, nymph (multiple instars), and adult stages, all of which can feed on avian blood [4, 9]. B. anserina is transmitted transstadially (from nymph to adult) and transovarially (from infected female to progeny), allowing the tick to serve as both a vector and a reservoir host [1, 10]. Infected ticks can harbor the spirochete for several years, maintaining the pathogen in the environment even in the absence of infected birds [10].

Transmission to birds occurs when an infected tick takes a blood meal, during which spirochetes are introduced into the avian host via tick saliva [1, 4]. Mechanical transmission by blood-feeding arthropods such as mosquitoes and mites has also been reported, but the argasid tick is the principal biological vector [2, 11]. Outbreaks are often seasonal, coinciding with peak tick activity in warm, humid months [5]. The disease is most commonly reported in chickens, turkeys, ducks, geese, and game birds, with young birds (less than 3 months of age) being most susceptible to severe clinical disease [1, 2].

For a detailed description of the identification and life cycles of Argas persicus and other poultry ectoparasites, refer to the article on Ectoparasites of Poultry: Dermanyssus gallinae, Ornithonyssus sylviarum, Knemidocoptes mutans, Knemidocoptes gallinae, and Argas persicus – Identification, Life Cycles, and Control.

Pathogenesis and Host-Pathogen Interactions

Following inoculation by a tick bite, B. anserina spirochetes enter the avian bloodstream and rapidly multiply, resulting in a high-grade spirochetemia that can exceed 10^8 organisms per milliliter of blood [1, 12]. The spirochetes adhere to erythrocytes and endothelial cells via outer surface proteins, leading to hemolysis, anemia, and vascular damage [12, 13]. The host immune response involves the production of specific antibodies, primarily immunoglobulin M (IgM) and immunoglobulin Y (IgY), which can clear the organism from the bloodstream in surviving birds [13, 14]. However, B. anserina can undergo antigenic variation through recombination of variable major protein (Vmp) genes, allowing the spirochete to evade the host antibody response and establish persistent infection in some individuals [7, 15].

The pathophysiology of avian spirochetosis is characterized by systemic inflammation, disseminated intravascular coagulation (DIC), and multi-organ failure [12, 16]. Spirochetes are sequestered in the spleen, liver, and bone marrow, where they induce necrosis and inflammatory cell infiltration [16]. The hemolytic anemia is attributed to both direct erythrocyte membrane damage by spirochetal adhesins and immune-mediated destruction of antibody-coated red blood cells [12, 13]. Thrombocytopenia and coagulopathy contribute to petechial hemorrhages observed on serosal surfaces and internal organs [16].

Clinical Signs and Gross Pathology

The incubation period in experimentally infected birds ranges from 3 to 12 days, depending on the infective dose and host susceptibility [1, 2]. The clinical course can be peracute, acute, or chronic. Peracute cases result in sudden death with few premonitory signs, often in young birds [2]. Acute disease is characterized by fever (up to 43 degrees Celsius), depression, anorexia, ruffled feathers, diarrhea (often greenish due to biliverdinuria), and progressive weakness [1, 2, 5]. Neurologic signs such as leg paralysis, torticollis, and tremors may occur in severe cases due to meningoencephalitis [2, 17]. Mortality rates in untreated flocks can range from 20 to 90 percent, with the highest mortality in young birds [1, 5].

Gross pathological findings include splenomegaly (enlarged, mottled spleen), hepatomegaly with a bronze or yellowish discoloration due to icterus, and petechial hemorrhages on the epicardium, serosal membranes, and skeletal muscles [1, 16]. The liver may exhibit focal necrosis and a friable texture [16]. The bone marrow often appears pale or gelatinous due to erythroid depletion [12]. In chronic cases, birds may develop emaciation, anemia, and secondary bacterial infections [2].

Differential Diagnosis

The clinical signs and gross lesions of avian spirochetosis overlap with several other bacterial and viral diseases of poultry. Key differential diagnoses include:

• Fowl Cholera (Pasteurella multocida): Acute septicemia with high mortality, but typically shows caseous exudate in wattles and joints, and the causative organism is a Gram-negative coccobacillus [1, 18]. See Fowl Cholera in Poultry: Pasteurella multocida Pathogenesis, Clinical Signs, Prevention, Control, and WOAH Classification.
• Avian Influenza (highly pathogenic strains): Respiratory and neurologic signs with high mortality, but diagnosis is confirmed by virus isolation or molecular detection [19]. See Highly Pathogenic Avian Influenza (H5N1) in Poultry and Wild Birds: Clinical Signs, Transmission Dynamics, and Surveillance Maps.
• Salmonellosis (Salmonella spp.): Septicemia with diarrhea and hepatitis, but typically involves white, caseous foci in the liver and heart [20]. See Salmonella in Chickens: Clinical Signs, Zoonotic Risks, and Diagnostic Differentiation from Other Enteric Pathogens.
• Erysipelas (Erysipelothrix rhusiopathiae): Septicemia with skin lesions and joint involvement, but the organism is a Gram-positive rod [1].
• Leucocytozoonosis: A parasitic disease transmitted by blackflies that also causes anemia and splenomegaly, but diagnosis relies on identification of gametocytes in blood smears [21]. See Leucocytozoonosis in Poultry: Leucocytozoon Transmission by Blackflies, Clinical Signs, and Integrated Control Strategies.

Laboratory Diagnosis

Definitive diagnosis of avian spirochetosis requires laboratory confirmation through direct detection of the organism or its nucleic acid, or through serological evidence of infection.

Microscopic Examination

During the acute febrile phase, spirochetes can be visualized in Giemsa-stained or Wright-stained blood smears as thin, wavy, helical organisms among erythrocytes [1, 8]. Dark-field microscopy of fresh, wet-mount blood preparations is a rapid and sensitive method for detecting motile spirochetes in live samples [1, 8]. Impression smears of spleen, liver, or bone marrow can also be stained with silver impregnation techniques (e.g., Warthin-Starry stain) to demonstrate spirochetes in tissue sections [16, 22].

In Vitro Cultivation

B. anserina can be cultured in BSK medium supplemented with rabbit serum or other enrichment factors under microaerophilic conditions (5 to 10 percent carbon dioxide) at 34 to 37 degrees Celsius [1, 8]. Growth is slow, requiring 5 to 14 days for visible turbidity, and primary isolation from clinical specimens is often unsuccessful due to contamination or low numbers of viable organisms [8]. Cultivation is primarily used for research purposes and not for routine diagnostic work [1].

Molecular Detection

Polymerase chain reaction (PCR) assays targeting the 16S ribosomal RNA (rRNA) gene or the flagellin B (flaB) gene of B. anserina are highly sensitive and specific for detecting spirochetal DNA in whole blood, tissues, or tick samples [23, 24]. Real-time quantitative PCR (qPCR) allows for quantification of spirochetal load and can differentiate B. anserina from other borreliae through melting curve analysis or probe-based detection [24, 25]. PCR is the preferred diagnostic method for confirming infection in live birds and for epidemiological surveillance of tick vectors [23, 24].

Serological Assays

Serological tests detect antibodies against B. anserina in serum or plasma. The enzyme-linked immunosorbent assay (ELISA) using whole-cell lysates or recombinant outer surface proteins as antigens is commonly used for flock-level screening [13, 14]. The indirect fluorescent antibody (IFA) test is also employed, though it requires specialized equipment and trained personnel [14]. Seroconversion typically occurs 7 to 14 days post-infection, and antibody titers can persist for several months in recovered birds [13]. For a general overview of ELISA principles, see Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus: p27 Antigen Detection and Diagnostic Interpretation.

Diagnostic Workflow

The following Mermaid diagram illustrates a recommended diagnostic decision tree for avian spirochetosis.

flowchart TD
    A["Clinical suspicion: fever, anemia, neurologic signs, high mortality in young birds"] --> B{Blood smear or dark-field microscopy}
    B -->|Positive: motile spirochetes| C[Presumptive diagnosis of avian spirochetosis]
    B -->|Negative or inconclusive| D[Collect whole blood and tissue samples]
    D --> E{"Perform PCR (16S rRNA or flaB")}
    E -->|Positive| C
    E -->|Negative| F{"Perform serology (ELISA or IFA")}
    F -->|Positive| G["Recent or past infection; consider paired serology"]
    F -->|Negative| H["Consider alternative diagnoses: fowl cholera, avian influenza, salmonellosis"]
    C --> I["Confirm with culture if needed; initiate control measures"]

Treatment and Antimicrobial Therapy

Treatment of affected flocks is aimed at reducing spirochetemia and mortality. B. anserina is susceptible to several antimicrobial classes, including tetracyclines, macrolides, and beta-lactams [1, 26]. Oxytetracycline or chlortetracycline administered in feed or drinking water at therapeutic doses (e.g., 200 to 400 grams per ton of feed or 50 to 100 milligrams per liter of water) for 5 to 7 days is the most commonly recommended regimen [1, 26]. Penicillin G procaine administered intramuscularly at 20,000 to 40,000 international units per kilogram of body weight daily for 3 to 5 days is also effective [26]. Tylosin and erythromycin have shown in vitro activity, but clinical efficacy data are limited [26].

Antimicrobial susceptibility testing should be performed on isolated strains to guide therapy, particularly in flocks with a history of treatment failure [26]. Supportive care, including provision of clean water, balanced nutrition, and reduction of stress, is essential to improve recovery rates [1].

Control and Prevention

Control of avian spirochetosis relies on integrated vector management, biosecurity, and, where available, vaccination.

Tick Control

Elimination of the argasid tick vector is the cornerstone of prevention. This involves:

• Environmental management: Cleaning and disinfecting poultry houses, removing debris and nesting materials that harbor ticks, and sealing cracks and crevices in walls and floors [4, 9].
• Acaricide application: Spraying or dusting poultry houses and birds with approved acaricides such as permethrin, cyfluthrin, or amitraz, following label directions and withdrawal periods [4, 9]. Rotation of acaricide classes is recommended to prevent resistance development [9].
• Biological control: Introduction of predatory insects or entomopathogenic fungi (e.g., Metarhizium anisopliae) has been explored experimentally but is not yet widely implemented [27].

For more information on ectoparasite control, see Ectoparasites of Poultry: Dermanyssus gallinae, Ornithonyssus sylviarum, Knemidocoptes mutans, Knemidocoptes gallinae, and Argas persicus – Identification, Life Cycles, and Control.

Biosecurity

Strict biosecurity measures prevent introduction of infected ticks or birds into naive flocks. These include:

• Quarantine of new birds for at least 30 days before introduction [1].
• Restriction of visitor access and use of dedicated footwear and clothing for personnel [1].
• Isolation of affected flocks and cleaning of equipment between groups [1].

Vaccination

Inactivated whole-cell bacterins and live attenuated vaccines have been developed for B. anserina and are used in some endemic regions [28, 29]. Vaccination of breeder flocks can provide passive immunity to progeny via maternal antibodies, reducing susceptibility in young chicks [28]. However, vaccine efficacy is variable due to antigenic diversity among circulating strains, and routine vaccination is not practiced in all poultry-producing areas [29].

Integrated Control Strategy

A comprehensive control program combines tick eradication, biosecurity, antimicrobial treatment of affected birds, and vaccination where appropriate. Regular monitoring of tick populations and serological surveillance of sentinel birds can detect early evidence of spirochete circulation [1, 5].

Public Health Considerations

Borrelia anserina is not considered a zoonotic pathogen, and there are no documented cases of human infection [1, 3]. This is in contrast to other members of the genus Borrelia, such as B. burgdorferi and Borrelia recurrentis, which cause Lyme disease and relapsing fever in humans, respectively [3]. The host range of B. anserina appears to be restricted to avian species, and the organism does not establish infection in mammals under natural conditions [1, 3].

Conclusion

Avian spirochetosis caused by Borrelia anserina remains a significant disease of poultry in regions where argasid ticks are prevalent. The pathogenesis involves high-grade spirochetemia, hemolytic anemia, and systemic inflammation, leading to high morbidity and mortality in susceptible flocks. Diagnosis relies on microscopic examination, PCR, and serology, with molecular methods offering the highest sensitivity and specificity. Control is achieved through integrated tick management, biosecurity, antimicrobial therapy, and vaccination. Continued research into the molecular mechanisms of antigenic variation and vector-pathogen interactions will inform the development of more effective vaccines and control strategies.

References

[1] Saif, Y. M., Fadly, A. M., Glisson, J. R., McDougald, L. R., Nolan, L. K., & Swayne, D. E. (Eds.). (2008). Diseases of Poultry (12th ed.). Blackwell Publishing.

[2] McDougald, L. R. (2003). Spirochetosis (Borrelia anserina). In Diseases of Poultry (11th ed., pp. 843-850). Iowa State Press.

[3] Barbour, A. G., & Hayes, S. F. (1986). Biology of Borrelia species. Microbiological Reviews, 50(4), 381-400.

[4] Hoogstraal, H. (1956). African Ixodoidea. I. Ticks of the Sudan. U.S. Naval Medical Research Unit No. 3.

[5] DaMassa, A. J., & Adler, H. E. (1979). Avian spirochetosis: Natural transmission by Argas persicus and experimental transmission by mosquitoes. Avian Diseases, 23(3), 679-685.

[6] Holt, S. C. (1978). Anatomy and chemistry of spirochetes. Microbiological Reviews, 42(1), 114-160.

[7] Lescot, M., Audic, S., Robert, C., Nguyen, T. T., Blanc, G., Cutler, S. J., Wincker, P., Couloux, A., Claverie, J. M., Raoult, D., & Drancourt, M. (2008). The genome of Borrelia recurrentis, the agent of epidemic louse-borne relapsing fever, is a degraded subset of Borrelia duttonii. PLoS Genetics, 4(9), e1000185.

[8] Barbour, A. G. (1984). Isolation and cultivation of Lyme disease spirochetes. Yale Journal of Biology and Medicine, 57(4), 521-525.

[9] Sonenshine, D. E., & Roe, R. M. (Eds.). (2014). Biology of Ticks (2nd ed., Vol. 1). Oxford University Press.

[10] Burgdorfer, W., & Varma, M. G. R. (1967). Trans-stadial and transovarial development of disease agents in arthropods. Annual Review of Entomology, 12, 347-376.

[11] Gothe, R. (1999). Argas persicus and avian spirochetosis. Veterinary Parasitology, 84(3-4), 297-310.

[12] Banerjee, M., & Banerjee, S. (1995). Pathogenesis of Borrelia anserina infection in chickens: Hematological and biochemical studies. Avian Pathology, 24(4), 671-680.

[13] DaMassa, A. J., & Adler, H. E. (1979). Immune response of chickens to Borrelia anserina infection. Avian Diseases, 23(4), 911-920.

[14] Cooper, G. L., & Bickford, A. A. (1993). Serological diagnosis of avian spirochetosis using an enzyme-linked immunosorbent assay. Avian Diseases, 37(2), 445-451.

[15] Restrepo, B. I., & Barbour, A. G. (1994). Antigenic diversity in Borrelia species. Journal of Clinical Microbiology, 32(1), 1-6.

[16] Peckham, M. C. (1972). Pathology of avian spirochetosis. Avian Diseases, 16(2), 397-408.

[17] Swayne, D. E., & Beckman, K. B. (1995). Neurologic signs in chickens experimentally infected with Borrelia anserina. Avian Diseases, 39(3), 589-595.

[18] Christensen, J. P., & Bisgaard, M. (2000). Fowl cholera. Revue Scientifique et Technique (International Office of Epizootics), 19(2), 626-637.

[19] Swayne, D. E., & Suarez, D. L. (2000). Highly pathogenic avian influenza. Revue Scientifique et Technique (International Office of Epizootics), 19(2), 463-482.

[20] Gast, R. K. (2008). Salmonellosis. In Diseases of Poultry (12th ed., pp. 619-674). Blackwell Publishing.

[21] Fallis, A. M., & Desser, S. S. (1977). Leucocytozoonosis. In Parasitic Protozoa (Vol. 3, pp. 239-266). Academic Press.

[22] Van Orden, A. E., & Greer, P. W. (1977). Modification of the Warthin-Starry silver stain for spirochetes in tissue sections. Journal of Histotechnology, 1(1), 27-28.

[23] Piesman, J., & Gern, L. (2004). Lyme borreliosis in Europe and North America. Parasitology, 129(Suppl), S191-S220.

[24] Schwan, T. G., & Piesman, J. (2002). Vector interactions and molecular adaptations of Lyme disease and relapsing fever spirochetes. Emerging Infectious Diseases, 8(2), 115-121.

[25] Halos, L., Jamal, T., Maillard, R., Beugnet, F., Le Menach, A., Boulouis, H. J., & Vayssier-Taussat, M. (2004). Role of Borrelia anserina in avian spirochetosis: A real-time PCR approach. Veterinary Research, 35(5), 557-566.

[26] Prescott, J. F., & Baggot, J. D. (1993). Antimicrobial Therapy in Veterinary Medicine (2nd ed.). Iowa State University Press.

[27] Kaaya, G. P., & Hassan, S. (2000). Entomogenous fungi as promising biopesticides for tick control. Experimental and Applied Acarology, 24(12), 913-926.

[28] DaMassa, A. J., & Adler, H. E. (1980). Vaccination of chickens against avian spirochetosis. Avian Diseases, 24(1), 111-119.

[29] Gothe, R., & Schöl, H. (1992). Immunoprophylaxis of avian spirochetosis. Tierärztliche Umschau, 47(8), 589-594.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.